Koninklijke Philips | PHG - Equity Capital And Reserves


Koninklijke Philips reported EUR11.42B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 24.93B 934M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Demant DKK 11.24B 1.4B Jun/2026
Dexcom USD 2.62B 335.5M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Fresenius EUR 19.7B 766M Jun/2026
General Electric Aerospace USD 17.64B 417M Jun/2026
Getinge SEK 30.94B 2.06B Jun/2026
Globus Medical USD 4.77B 36.29M Jun/2026
GN Store Nord DKK 10.27B 146M Jun/2026
Hitachi JPY 6.57T 5.39B Jun/2026
Idexx Laboratories USD 1.61B 56.47M Jun/2026
Insulet USD 1.42B 119.6M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 18.17B 693.9M Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Koninklijke Philips EUR 11.42B 1.45B Mar/2026
Medtronic USD 50.23B 160M Jun/2026
Philips EUR 11.48B 84M Jun/2026
ResMed USD 6.59B 93.48M Jun/2026
Smith & Nephew USD 5.18B 356M Jun/2026
Steris USD 7.21B 23.1M Jun/2026
Stryker USD 22.98B 559M Mar/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 1.66T 77.51B Jun/2026
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026